(Q46468735)

22 December 2017

title

Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results (English)

1 reference

22 December 2017

1 reference

Shouwei Li

1

1 reference

22 December 2017

Tao Jiang

series ordinal

2

1 reference

22 December 2017

Guilin Li

series ordinal

3

1 reference

22 December 2017

Zhongcheng Wang

series ordinal

4

1 reference

22 December 2017

publication date

1 July 2008

1 reference

22 December 2017

published in

Neurological Research

1 reference

22 December 2017

volume

30

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

567-570

1 reference

22 December 2017

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

cites work

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297913

21 January 2018

Identifiers

DOI

10.1179/174313208X297913

1 reference

22 December 2017

1 reference

22 December 2017